Introduction
Age-related mitochondrial dysfunction is implicated in the degeneration of the substantia nigra (SN), where neuronal loss causes the movement disorder in Parkinson's disease (PD).
Mitochondrial respiratory chain (RC) deficiency has been reported in both SN homogenate (Pyle et al., 2016; Schapira et al., 1989) and individual SN neurons (Grunewald et al., 2014; Grunewald et al., 2016) from those affected by PD, and nigrostriatal degeneration (Tzoulis et al., 2013) . In cytochrome c oxidase (COX)-deficient neurons from aged individuals and PD patients, the level of mitochondrial DNA (mtDNA) deletion is strikingly high (~50%) compared to other post-mitotic tissues (Bender et al., 2006; Kraytsberg et al., 2006) . These mtDNA deletions are believed to be somatically acquired, with different deletions clonally expanded within each SN neuron (Reeve et al., 2008) . It is interesting that the pattern of acquired multiple mtDNA deletions seen in aged and PD neurons shows consistency with those from patients who carry mutations in the mitochondrial polymerase (POLG) gene (Nido et al., 2017; Reeve et al., 2008) . Individuals with POLG mutations accumulate mtDNA deletions with advancing age, and alongside other neurological symptoms such as ataxia and dementia, some patients may develop Parkinsonism due to nigrostriatal degeneration (Bandettini di Poggio et al., 2013; Luoma et al., 2004; Miguel et al., 2014; Rempe et al., 2016) . These findings highlight the potential consequence of clonally expanded mtDNA mutations and related biochemical defects on the survival of SN neurons. However, SN neurons appear to exhibit differential responses to mitochondrial defects, as severe neuronal loss is only found in PD and some POLG patients (Reeve et al., 2013) , whilst this neuronal population is relatively spared in healthy ageing and individuals with mitochondrial disease caused by pathogenic mtDNA point mutations or single deletions (Reeve et al., 2013) . These mtDNA mutations will have been maternally inherited or occurred during embryonic development, suggesting an adaptive response in SN neurons exposed to mitochondrial defects from the earliest stages of life which allows them to survive into later life.
Understanding the mechanism behind such an adaptive response will be essential for the future development of PD neuroprotective treatments.
J o u r n a l P r e -p r o o f 6 Both total mtDNA copy number and deletion level were recently found to increase with advancing age in individual SN neurons from healthy aged individuals (Dolle et al., 2016) , with similar changes and an enhancement of mitochondrial function detected in dopaminergic neurons from a premature ageing model (Perier et al., 2013) . These data suggest that a response of SN neurons to mitochondrial dysfunction may be implemented through the adjustment of mitochondrial population maintenance. This responsive mechanism may be impaired in PD cases, as a decrease in the correlation between mtDNA copy number and deletion level has been suggested (Dolle et al., 2016) , further supported by the finding of decreased expression of mitochondrial transcription factor A (TFAM) (Grunewald et al., 2016) . TFAM functions in the maintenance of mtDNA nucleoid structure, is a critical regulator of mtDNA transcription and primer of mtDNA synthesis (Bonawitz et al., 2006) .
To validate whether impaired mitochondrial maintenance is only present in PD neurons, and to explore the potential role of nuclear-mitochondrial interaction in the regulation of this process, a comprehensive comparison of single SN neurons exposed to different types of mtDNA defect was performed. Neurons from idiopathic PD patients and healthy aged individuals were compared to mitochondrial disease patients with mtDNA point mutations or single, large-scale deletions and a well-preserved SN neuronal population (Reeve et al., 2013) . We also investigated individuals with multiple mtDNA deletions due to nuclear gene defects affecting mtDNA maintenance, these cases have variable levels of SN neuronal loss.
The selection of patients enabled us to evaluate the contribution of age, mtDNA mutation type and inheritance pattern to the response of SN neurons to mitochondrial dysfunction, whilst identifying which changes are associated only with mitochondrial dysfunction and which were additionally associated with neurodegeneration.
J o u r n a l P r e -p r o o f

Materials and Methods Tissue
All post-mortem tissue samples were obtained from the Newcastle Brain Tissue Resource (NBTR), and their use conformed to the Local Research Ethics Committee and the United Kingdom Medical Research Council's Guidelines on the use of tissue in medical research.
The study included 12 cases with clinically and pathologically confirmed mitochondrial disease (mean, 49 years old; five males, seven females). Seven patients had inherited or early-onset mtDNA mutations, including point mutations and a single, large-scale mtDNA deletion and five patients had acquired multiple mtDNA deletions due to POLG mutations (n=4), or an unconfirmed nuclear gene mutation at time of writing. Eight PD patients (mean, 81 years old; seven males, one female) were included in this cohort, pathological features and details of mutations are summarised in Table 1 . Fifteen control subjects with a broad age range (mean, 75 years old; nine males, six females) were also investigated, while age matched controls were sought, it was difficult to find exact matches to the younger mitochondrial disease cases ( Table 2) .
Multi-label immunofluorescence
Formalin-fixed paraffin-embedded (FFPE) midbrain sections (5µm) were used to perform quadruple-label immunofluorescence (IF) (Rocha et al., 2015) . A combination of four mitochondrial protein antibodies, including anti-NDUFB8 (Abcam, ab110242, a nuclearencoded complex I subunit), anti-MTCOI (Abcam, ab14705, a mitochondrial-encoded complex IV subunit), mitochondrial mass marker anti-porin (VDAC1, Abcam, ab14734) and anti-TFAM (Abcam, ab176558) was employed to assess the relationship between TFAM and mitochondrial deficiency. The presence of neuromelanin and a clear nucleus in brightfield images were used to identify individual SN neurons. Healthy aged (n=15, counted neurons=695), point mutation (n=4, neurons=183), single, large-scale mtDNA deletion (n=1, neurons=50), multiple mtDNA deletion (n=5, neurons=233) and PD (n=7, neurons=265) cases were included. Imaging and mean densitometric measurement were performed, blinded for diseases status, with an Apotome Axio Imager Z2 microscope and Zen Blue software (Carl Zeiss).
Laser-microdissection of single neurons
For single neuron DNA extraction, frozen midbrain sections at 15µm thickness were stained for TFAM, COXIV, TH and Hoechst (25μg/ml) using a similar multi-label IF assay as above.
Tiled images were captured by Zen Blue in Axio Imager M1 microscope (Carl Zeiss) in order to map individual TH-positive neurons within the SN. Densitometric values of COXIV and TFAM signal were obtained for the dissected neurons. Imaged cryosections were prepared for laser microdissection by removing coverslips and dehydrating through an ascending ethanol gradient (70%, 95%, 100%, and 100% v/v). The neurons of interest were outlined based on their TH signal in the 488nm channel and laser-captured using the PALM laser micro-dissection system (Zeiss). For each section, over 25 single neurons were captured and collected individually in 10µl of Tris-Tween lysis buffer (0.5M Tris-HCl, 0.5% Tween-20, 1% Proteinase K, pH 8.5). Single cells were lysed for 2 hours at 55°C, followed by 10 minutes at 95°C.
J o u r n a l P r e -p r o o f Triplex real-time PCR
The triplex real-time PCR assay was performed using previously optimized primers for MT-ND1, MT-ND4 and D-loop (Rygiel et al., 2015a) . Major arc and minor arc mtDNA deletions were determined as previously (Rygiel et al., 2015a) . A threshold level of 33.33% is used to define the presence of deletions when MT-ND1/D-Loop or MT-ND4/D-Loop deletion levels are calculated (Rygiel et al., 2015b) . For individual TH-positive neurons, total mtDNA copy number was determined by D-Loop copy number (per area), and MT-ND4 copy number (per area) was used as the wild type (non-MT-ND4 deleted) copy number metric. Correlation between mitochondrial copy number and TFAM expression within individual captured neurons were also performed via matching of mapped neurons. Individual TH-positive neurons from healthy aged (n=8, neurons=175); point mutation (n=4, neurons=55); single, large-scale deletion (n=1, neurons=26); multiple deletion (n=3, neurons=58) and PD (n=6, neurons=119) cases were investigated.
Statistical analysis
Densitometric values of fluorescent signal within the SN neurons was background corrected using no-primary controls and log-transformed for normalisation. Expression levels of complex I, complex IV and TFAM were normalized to mitochondrial mass (the level of porin) and represented as z scores for individual neurons. The z scores were determined by the standard deviation of each neuron from the range of the neuronal population from healthy aged individuals (Rocha et al., 2015) . Categorization of protein expression level was defined using z scores: <-2 as deficiency; -1 to -2 as reduction; >-1 as normal. Due to the fact that these parameters were set based on the data distribution of all control cases, what we established here is a semi-quantitative measure of protein expression level.
Statistical analyses were performed using Graph Pad Prism (v.8.0.1) and R (Team, 2018) software. Differences between groups in terms of protein expression and mtDNA copy number were assessed by one-way ANOVA. The Spearman rank correlation coefficient (r 2 ) and associated p value were used in correlative analysis of protein targets. Differences J o u r n a l P r e -p r o o f between the correlative relationships were assessed by comparison of regression slope and correlation coefficients. Frequency distributions were calculated to describe the parameters of mtDNA maintenance. 27.3% showing CI deficiency and 9.09% complex IV deficiency. In the patient with multiple mtDNA deletions for which the nuclear genetic cause was undetermined, there was 6.67% combined deficiency, 3.33% complex I deficiency and 18.3% complex IV deficiency. There was a high level of isolated complex I deficiency in the patient with a single, large-scale mtDNA deletion (64.0% deficiency and 34.0% reduction). This mtDNA deletion affects complex I subunit genes but not complex IV genes (Rocha et al., 2018) . The point mutation cases mainly exhibited complex I reduction, with or without a corresponding decrease in J o u r n a l P r e -p r o o f complex IV expression, with only 2.1% complex IV deficient neurons with complex I reduction in MERRF1. These changes in complex I and complex IV expression are consistent with results obtained using single-label immunohistochemistry (overlapping cases labelled in Table 1 ) (Reeve et al., 2013) .
Results
Expression of respiratory chain subunits in SN neurons
We could also examine these deficiencies in detail in PD cases and controls. There was evidence of complex I and complex IV deficient neurons in PD cases, with complex I more severely affected than complex IV. Interestingly, neurons with both complex I and complex IV deficiency were sparsely found, suggesting that these cells may have degenerated during the progression of the disease. A small percentage of complex I and complex IV deficient neurons was detected in the healthy aged SN populations. Overall as for the PD cases, there was more complex I deficiency and reduction than complex IV loss (Figure 1c-d) .
Changes in TFAM expression in SN neurons with different mitochondrial defects
Next, we investigated alterations in TFAM expression, determined by z score, in SN neurons with different mtDNA mutations (Figure 2a ). There was a significant increase in TFAM expression in patients with mtDNA point mutations and multiple deletions compared to controls (F (4, 1359) =49.26, p=0.0078, point mutations; p=0.0003, multiple deletions, ANOVA), however, the controls were much older (Figure 2b) . PD neurons showed significantly lower TFAM expression than neurons from all the other four groups (F (4, 1359) =49.26, p<0.0001, ANOVA), suggesting this adaptive neuronal response may be impaired in PD cases. This trend was nicely reproduced in those neurons with reduced complex I expression (Figure 2c) , where TFAM expression was significantly lower in patients with PD than the others (F (4, 292) =45.58, p<0.0001, ANOVA).
MtDNA deletion levels in single TH-positive neurons
To ascertain whether the observed changes in TFAM expression were also associated with altered mtDNA homeostasis in SN neurons, we measured both mtDNA copy number and deletion level in individual neurons from all groups. Only total copy number data was obtained in cases with mtDNA point mutations, due to the absence of deletion, and the J o u r n a l P r e -p r o o f threshold of point mutation heteroplasmy was reported to be much higher than that of deletions (Moslemi et al., 1998; Reeve et al., 2013) . As expected, MT-ND4 deletions were detected in healthy aged TH-positive neurons, (mean age 74.5 years, n=8, total counted neurons=175) with the deletion level generally falling between 40%-80% (Figure 3a) .
Comparable deletion levels were found in the cases with multiple mtDNA deletions (mean age 65.3 years, n=3, counted neurons=58) and PD (mean age 81.2 years, n=6, counted neurons=119). In the single, large-scale mtDNA deletion patient (age 40 years, counted neurons 26), the level of deletion load was higher and fell within a smaller range (Figure 3a) .
Prominent MT-ND1 deletions (60%-80%) were also detected in neurons from multiple deletion cases (Reeve et al., 2008) , most of which came from the POLG2 case (Figure 3b) .
SN neurons from ageing controls and PD cases also showed MT-ND1 deletions, however the level was much lower.
Multifaceted description of mtDNA copy number changes in TH-positive neurons
Total copy number was significantly lower in patients with mtDNA point mutations, multiple mtDNA deletions and PD, compared to aged controls (F (4, 428) =5.883, p=0.0071, point mutation; p=0.0001, multiple deletion; p=0.0306, PD, ANOVA; Figure 3c ). For wild type (non-MT-ND4 deleted) copy number, a significant decrease was seen in the cases with single mtDNA deletion and multiple mtDNA deletions, which is more likely a combined consequence of low total copy number and high deletion load (Figure 3d) . The data show evidence of mtDNA depletion in PD neurons, however large individual diversity was seen in these cases, for example PD2 and PD4 demonstrate relative high copy number whereas PD3 and PD7 showed the reverse (Figure 3-1) . Using the average level of complex I and complex IV expression, we demonstrated a significant non-linear regression between the proportion of RC normal neurons and wild type mtDNA copy number in the available cases excluding those with mtDNA point mutations (df=14, r 2 =55.53%, One-phase decay; Figure   3e ). It is interesting that this relationship did not reappear within RC expression and mtDNA deletion load (Figure 3f ).
J o u r n a l P r e -p r o o f
Investigation of mitochondrial biogenesis
Expression of TFAM is closely regulated by peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α and its transcription coactivators. We therefore measured the expression of PGC-1α alongside two markers for mitochondrial mass (porin and COXIV) in individual TH-positive neurons (Figure 4a) . No obvious changes in mitochondrial mass within individual neurons were observed between groups, based on the level of porin and COXIV expression (Figure 4b-c ). There is a lower level of PGC-1α expression in TH-positive neurons in multiple mtDNA deletions and PD, which was not found to be statistically significant (Figure 4d) . A decline in PGC-1α expression with advancing age was also found in healthy ageing cases (r 2 =29.19%), and such a correlation was not seen with changes in mitochondrial mass (Figure 4e) . However, given the lack of young individuals in this study, it's impossible to trace the actual alterations in PGC-1α expression over a human life time, therefore difficult to interpret the correlation between age and mitochondrial biogenesis.
In addition, PD neurons demonstrated the weakest correlation (r 2 =7.66%) between PGC-1α and porin expression among all group studied (mtDNA point mutations (r 2 =45.15%), multiple deletions (r 2 =19.43%) and healthy ageing (r 2 =34.39%)) ( Supplementary Figure 4-1) . This correlative relationship was significantly different, in terms of both regression slope and correlation coefficient, between individuals with PD and healthy aged individuals (p=0.024, z score= 5.12). There was no significant correlation observed between the average level of PGC-1α and TFAM expression from the two batches of immunostaining ( Supplementary   Figure 4-2) .
Discussion
Our primary objective was to understand the response of dopaminergic neurons to different types of mitochondrial defect. This was achieved through investigation of mitochondrial RC subunit expression, mtDNA homeostasis, and via analysis of TFAM expression the potential J o u r n a l P r e -p r o o f regulatory mechanism behind this neuronal response. Although mitochondrial RC phenotypes and mtDNA homeostasis within SN neurons has been investigated in several post-mortem studies (Flones et al., 2018; Grunewald et al., 2016; Reeve et al., 2013; Reeve et al., 2008; Tzoulis et al., 2013) , the value of this study was the inclusion of a mitochondrial disease cohort to draw a comparison with PD and healthy ageing. This is important to increase the understanding of the contribution of mitochondrial dysfunction to SN neuronal survival, as similar properties such as somatic mtDNA deletions are shared between neurons of aged, PD and POLG patients with only severe neuronal loss routinely identified in PD.
One important advantage of our study is the application of multi-label immunofluorescence.
Though RC deficiency in SN neurons of mitochondrial disease cases has been studied by immunohistochemistry (Reeve et al., 2013) , images acquired from quadruple immunofluorescence allowed the assessment of the varying degree and combination of RC protein expression, by objectively quantifying the subtle changes in fluorescent intensity. The variable degrees of complex I and complex IV expression observed in the SN neurons fits in well with the expected variability in mtDNA heteroplasmy level, and type of mutation (e.g. deletions of different sites and size) in patients with acquired mtDNA mutations. Our data revealed significantly higher level of complex I and complex IV deficiency in SN neurons of mitochondrial disease patients who harbored mtDNA deletions, compared to the translational changes that result from mtDNA point mutations in tRNA genes. We observed high MT-ND4 deletion load and marked complex I dysfunction in single, large-scale deletion and multiple mtDNA deletions cases. In cases of PD and healthy ageing, we found much less complex I or complex IV deficiency, of which complex I deficiency is comparable between these two groups whereas complex IV deficiency is higher in the healthy ageing group. This is possibly due to the increased vulnerability of PD neurons to mitochondrial dysfunction or the large individual diversity within the healthy aged individuals (Supplementary Figure 1-1) 
J o u r n a l P r e -p r o o f
High mtDNA total copy number was observed in aged SN neurons and some PD patients, compared to those from mid-life POLG patients, despite the fact that these neurons carried high levels of mtDNA deletions. Meanwhile, the relationship of wild type mtDNA copy number and RC expression showed a tendency for RC protein deficiency to occur in neurons with low mtDNA copy number. Our data provide evidence to support the hypothesis of mtDNA copy number as a determining factor in biochemical defect phenotype rather than the heteroplasmy level (Durham et al., 2007; Jiang et al., 2017; Stewart and Chinnery, 2015) . Therefore, the SN neuronal loss in some of the POLG patients was likely a combined consequence of a severe mitochondrial biochemical defect and low mtDNA copy number. This low mtDNA copy number could be due to impaired POLG function or compromised ability to expand the initial mtDNA pool in the early-stages of life (Stewart et al., 2011; Tzoulis et al., 2014) . Limitations in interpretation of the findings presented in this study is due to the lack of young control data for reference.
These data further support the beneficial role of an increase in mtDNA copy number in surviving aged SN neurons, and indicate an attempt of these neurons to rescue the increasing mtDNA mutation load which occurs with advancing age (Dolle et al., 2016) .
Hence, with a mild RC defect identified in PD neurons, a reduction in TFAM expression might be a key factor in increasing vulnerability of SN neurons to mitochondrial dysfunction, and age-related degeneration in these individuals. A significant decrease in TFAM expression was inferred as a sign of impaired mitochondrial homeostasis in PD patients.
Low TFAM expression could influence mtDNA D-Loop stability causing impaired regulation of mtDNA expression (reviewed in Picca and Lezza (2015) ), and dysregulation of mitochondrial proteases, such as TFAM targeted AAA+ protease, LonP1. These alterations could be further explored by electrophoretic mobility shift assay (EMSA) of altered mtDNA structure (Nicholls et al., 2018) , transcriptomic analysis of key mitochondrial genes, and via the measurement of LonP1 expression and activity (Lu et al., 2013) . Another line of evidence supporting the association of TFAM with SN neuronal adaption, is the increase in TFAM Our data showed significantly weaker correlations of PGC-1α with both COXIV and porin in PD neurons than those in aged controls, indicating impairments in the regulatory signalling of the PGC-1α-mitochondrial axis, as reflected by the significant decrease of TFAM expression in PD cases. The expression level of PGC-1α protein failed to respond to TFAM deficiency in an active feedback manner, in fact, it demonstrated a decrease trend in some PD cases. These findings are consistent with the low expression level of the PGC-1α gene and its responsive nuclear-encoded RC genes in PD neurons (Zheng et al., 2010) . However, the intricate interactions between PGC-1α and its downstream transcriptional factors, and between these transcriptional factors and their target genes, alongside post-translation modification of the involved proteins, make it difficult to draw conclusions from simple measurements of protein expression (reviewed in Islam et al. (2018) ).
Conclusion
Overall, all of the data presented here and previously (Dolle et al., 2016; Grunewald et al., 2016; Reeve et al., 2013) suggests an increased sensitivity of SN neurons to mitochondrial deficiency and indicates that this relates in part to TFAM and nuclear retrograde signaling in PD patients. The decrease in TFAM could be a sign of unstable mtDNA structure and a collapse of nuclear-mitochondrial regulation, leading to impaired mtDNA maintenance, which accelerates the neuronal loss. We hypothesize that impaired nuclear control of mitochondrial biogenesis is a critical aspect that pushes SN neurons towards early loss due to age-related mitochondrial dysfunction in PD. Further investigation of the transcriptional activity of the mitochondrial genome is needed and a wider screening for related nuclear signal pathways may be implicated. Scale bar, 20 µm. Journal Pre-proof  A significant decrease in TFAM expression and total mtDNA copy number in PD neurons which carried somatic multiple mtDNA deletions.
 Such decreases in TFAM expression were not present in SN neurons from POLG patients, which also harbour high levels of multiple mtDNA deletions and respiratory chain deficiencies within SN neurons.
 Compared to mtDNA deletion load, the maintenance of mtDNA copy number could have a more determinant role in the OXPHOS phenotype of mitochondria in the SN neuronal population.
